Filing Details
- Accession Number:
- 0001209191-21-041062
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-16 18:22:15
- Reporting Period:
- 2021-06-15
- Accepted Time:
- 2021-06-16 18:22:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1817713 | Janux Therapeutics Inc. | JANX | Pharmaceutical Preparations (2834) | 822289112 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1863287 | Bregua Corp | Wickhams Cay P.o. Box 146 Road Town, Tortola D8 VG1110 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-15 | 1,138,665 | $0.00 | 1,138,665 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2021-06-15 | 1,630,428 | $0.00 | 2,769,093 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2021-06-15 | 674,211 | $0.00 | 3,443,304 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2021-06-15 | 247,123 | $0.00 | 3,690,427 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2021-06-15 | 58,823 | $17.00 | 3,749,250 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series Seed Convertible Preferred Stock | Disposition | 2021-06-15 | 888,888 | $0.00 | 1,138,665 | $0.00 |
| Common Stock | Series Seed 2 Convertible Preferred Stock | Disposition | 2021-06-15 | 1,272,778 | $0.00 | 1,630,428 | $0.00 |
| Common Stock | Series A Convertible Preferred Stock | Disposition | 2021-06-15 | 526,316 | $0.00 | 674,211 | $0.00 |
| Common Stock | Series B Convertible Preferred Stock | Disposition | 2021-06-15 | 192,914 | $0.00 | 247,123 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- Each share of Series Seed Convertible Preferred Stock, Series Seed 2 Convertible Preferred Stock, Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the "Preferred Stock") converted into 1.281 shares of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date.
- These securities are held directly by Bregua Corporation (Bregua). Klaus Dorner is the Director of Bregua and may be deemed to have voting and investment power with respect to the shares held by Bregua and as a result may be deemed to have beneficial ownership of such shares. Mr. Dorner disclaims beneficial ownership of all shares held by Bregua, except to the extent of his actual pecuniary interest therein, if any.
- The shares were purchased in the Issuer's initial public offering.
Billionaire Hedge Funds
